Recombinant FCRL5 (Cevostamab Biosimilar) antibody

Catalog No. ABIN7813231

This Humanized Chimeric antibody specifically detects FCRL5 (Cevostamab Biosimilar) in . It exhibits reactivity toward Human.

Quick Overview for Recombinant FCRL5 (Cevostamab Biosimilar) antibody (ABIN7813231)

Target: FCRL5 (Cevostamab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This FCRL5 (Cevostamab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-FCRL5 (Cevostamab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Cevostamab Biosimilar - Anti-CD307e,FCRL5 and CD3E mAb - Research Grade

Characteristics: IgG1-kappa

Isotype: IgG1, kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: 0.01M PBS, pH 7.4.

Handling Advice: Avoid repeated freeze-thaw cycles

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: 4°C for short term (1 week), store at -20°C to -80°C for long term(1 year), Avoid repeated freeze-thaw cycles

Expiry Date: 12 months

Target Details for FCRL5 (Cevostamab Biosimilar)

Target: FCRL5 (Cevostamab Biosimilar)

Alternative Name: Cevostamab Biosimilar

Target Type: Biosimilar

Background: Anti-CD307e, Anti-FCRL5, Anti-CD3E, Bispecific, BFCR-4350-A, BFCR-4350A, RG-6160, RO-7187797,

UniProt: Q96RD9, P07766

CAS-No: CAS: 2249888-53-5